Micafungin alters the expression of genes related to cell wall integrity in Candida albicans biofilms

Japanese Journal of Infectious Diseases

Volumn 63, Issue 5, 2010, Pages 355-357

  Kaneko, Yukihiro ^a   Ohno, Hideaki ^a   Kohno, Shigeru ^b   Miyazaki, Yoshitsugu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CELL PROTEIN; CHITIN; CHITIN SYNTHASE; CHITIN SYNTHASE 1; CHITIN SYNTHASE 2; CHITIN SYNTHASE 3; CHITIN SYNTHASE 4; CHITIN SYNTHASE 8; MICAFUNGIN; PROTEIN CRZ2; PROTEIN UTR2; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CARBOHYDRATE METABOLISM; CELL STRESS; CELL WALL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; FUNGAL CELL WALL; GENE EXPRESSION REGULATION; NONHUMAN; PHYSICAL TOLERANCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CELL WALL; CHITIN SYNTHASE; DNA PRIMERS; ECHINOCANDINS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION; LIPOPEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, FUNGAL; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 77957747344     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Pappas, P.G., Kauffman, C.A., Andes, D., et al (2009): Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis., 48, 503-535.
2. Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., et al. (2007): Micafungin versus liposomal amphotericin Bfor candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet, 369, 1519-1527.
3. Kaneko, Y., Ohno, H., Fukazawa, H., et al. (2010): Anti-Can-dida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses. Med. Mycol., 48, 606-612.
4. Jacobson, M.J., Steckelberg, K.E., Piper, K.E. et al (2009): In vitro activity of micafungin against planktonic and sessile Candida albicans isolates. Antimicrob. Agents Chemother., 53, 2638-2639.
5. Kuhn, D.M., George, T., Chandra, J., et al. (2002): Antifungal susceptibility of Candida biofilms: unique efficacy of amphoteri-cin Blipid formulations and echinocandins. Antimicrob. Agents Chemother., 46, 1773-1780.
6. Niimi, K., Monk, B.C., Hirai, A., et al. (2010): Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity. J. Antimicrob. Chemother., 65, 842-852.
7. Kaneko, Y., Ohno, H., Imamura, Y., et al. (2009): The effects of an Hsp90 inhibitor on the paradoxical effect. Jpn. J. Infect. Dis., 62, 392-393.
8. Cao, Y.Y., Cao, Y.B., Xu, Z., et al. (2005): cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob. Agents Chemother., 49, 584-589.
9. Dunkler, A., Walther, A., Specht, C.A., et al. (2005): Candida albicans CHT3 encodes the functional homolog of the Cts1 chitinase of Saccharomyces cerevisiae. Fungal Genet. Biol., 42, 935-947.
10. Drakulovski, P., Dunyach, C., Bertout, S., et al. (2009): FKS1 in-dependent mechanisms of resistance to caspofungin in Candida albicans. Abstract 5M354. 49th Interscience Conference on An-timicrobial Agents and Chemotherapy, United States, 12 to 15 September 2009.
11. Singh, S.D., Robbins, N., Zaas, A.K., et al. (2009): Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog., 5, e1000532.
12. Karababa, M., Valentino, E., Pardini, G., et al. (2006): CRZ1, a target of the calcineurin pathway in Candida albicans. Mol. Microbiol., 59, 1429-1451.